XRAY, US9839191015

Dentsply Sirona Stock - Director steps up insider buying

17.06.2026 - 18:56:33 | ad-hoc-news.de

Dentsply Sirona stock draws fresh attention after board member Clyde Hosein bought 6,500 shares in the open market. The mid-cap dental specialist remains under pressure, making this insider move notable for investors watching sentiment on the name.

XRAY, US9839191015
XRAY, US9839191015

Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 18:53 CET. Details in the imprint.

Dentsply Sirona (US9839191015) is back on investors' radar after a board member increased his stake. Director Clyde Hosein bought 6,500 shares in the open market on 06/15/2026, according to a recent Form 4 filing with the SEC.

Go deeper

All news and analysis on Dentsply Sirona stock

Background reports, regulatory filings and market data on Dentsply Sirona are bundled in the ad hoc news topic section for this stock.

Insider buys 6,500 XRAY shares

The Form 4 shows that Hosein acquired 6,500 Dentsply Sirona shares at $9.985 each, for a total of about $64,900, coded as an open-market purchase (transaction code P). His direct holdings rose to 70,575.456 shares after the trade, according to the SEC filing. Key details of the Form 4 are summarized by StockTitan.

Financial portals describe the purchase as an insider confidence signal at a time when the stock trades close to its 52-week low. Investing.com notes that the transaction value was approximately $64,902 and highlights that the shares were bought on 06/15/2026. An Investing.com report covers the transaction value and context.

Operational backdrop and strategy

Dentsply Sirona presents itself as a global dental products and technologies group, with activity spanning equipment, digital dentistry and consumables. In recent quarters, management has focused on simplifying the portfolio and driving margins through cost actions and efficiency programs, as laid out in recent earnings materials.

Analyst commentary gathered by market-data platforms describes profitability as still below historic levels, with leverage elevated after past challenges. A TipRanks-based analysis points to weaker profitability and a pressured balance sheet despite positive free cash flow trends.

What the company sells

Dentsply Sirona earns most of its revenue from professional dental products, including imaging systems, treatment centers, CAD/CAM solutions and consumables used by dentists and dental laboratories worldwide. Flagship offerings include digital chairside systems for restorations and endodontic instruments for root-canal procedures.

Where the stock trades today

The shares of Dentsply Sirona (US9839191015) trade on Nasdaq at $10.45 as of 06/17/2026, 16:30 ET.

Key facts on Dentsply Sirona stock

  • Company: Dentsply Sirona Inc.
  • ISIN: US9839191015
  • WKN: 265049
  • Ticker: XRAY
  • Venue: Nasdaq
  • Price (as of 06/17/2026, 16:30 ET): 10.45 USD
  • Market cap: 4,38 billion USD (as of 06/17/2026)
  • Sector / Industry: Health Care / Medical Equipment
  • Index membership: S&P MidCap 400
  • Next earnings date: 08/08/2026

More on Dentsply Sirona stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US9839191015 | XRAY | boerse | 69565031 | bgmi